FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 340:1962-1968 June 24, 1999 Number 25 Next

	Full Text PDF Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background Vitamin A supplementation may reduce the risk of chronic lung disease and sepsis in extremely-low-birth-weight infants. The results of our pilot study suggested that a dose of 5000 IU administered intramuscularly three times per week for four weeks was more effective than the lower doses given in past trials.

Methods We performed a multicenter, blinded, randomized trial to assess the effectiveness and safety of this regimen as compared with sham treatment in 807 infants in need of respiratory support 24 hours after birth. The mean birth weight was 770 g in the vitamin A group and 769 g in the control group, and the respective gestational ages were 26.8 and 26.7 weeks.

Results By 36 weeks' postmenstrual age, 59 of the 405 infants (15 percent) in the vitamin A group and 55 of the 402 infants (14 percent) in the control group had died. The primary outcome — death or chronic lung disease at 36 weeks' postmenstrual age — occurred in significantly fewer infants in the vitamin A group than in the control group (55 percent vs. 62 percent; relative risk, 0.89; 95 percent confidence interval, 0.80 to 0.99). Overall, 1 additional infant survived without chronic lung disease for every 14 to 15 infants who received vitamin A supplements. The proportions of infants in the vitamin A group and the control group who had signs of potential vitamin A toxicity were similar. The proportion of infants with serum retinol values below 20 µg per deciliter (0.70 µmol per liter) was lower in the vitamin A group than in the control group (25 percent vs. 54 percent, P<0.001).

Conclusions Intramuscular administration of 5000 IU of vitamin A three times per week for four weeks reduced biochemical evidence of vitamin A deficiency and slightly decreased the risk of chronic lung disease in extremely-low-birth-weight infants.

Source Information

From the University of Texas Southwestern Medical Center, Dallas (J.E.T., K.A.K.); the National Institute of Child Health and Human Development, Bethesda, Md. (L.L.W.); Women and Infant's Hospital, Providence, R.I. (W.O.); George Washington University Biostatistics Center, Rockville, Md. (L.M.); Yale University, New Haven, Conn. (R.A.E.); Emory University, Atlanta (B.J.S.); Indiana University, Indianapolis (J.A.L.); Stanford University, Stanford, Calif. (D.K.S.); University of Miami, Miami (C.R.B.); University of Tennessee, Memphis (S.B.K.); and Case Western Reserve University, Cleveland (A.A.F.). Other authors were Edward F. Donovan, M.D., M.P.H., University of Cincinnati, Cincinnati; Waldemar A. Carlo, M.D., University of Alabama, Birmingham; Seetha Shankaran, M.D., Wayne State University, Detroit; Ann R. Stark, M.D., Brigham and Women's Hospital, Boston; Lu-Ann Papile, M.D., University of New Mexico, Albuquerque; Alan Jobe, M.D., Ph.D., Children's Hospital Medical Center, Cincinnati; Maria Stacewicz-Sapuntzakis, Ph.D., University of Illinois at Chicago, Chicago; and Joel Verter, Ph.D., George Washington University Biostatistics Center, Rockville, Md.

Address reprint requests to Dr. Tyson at UT Houston, 6431 Fannin, Suite 3.228, Houston, TX 77030.

Full Text of this Article

Related Letters:

Vitamin A Supplementation for Extremely-Low-Birth-Weight Infants
Bental Y. A., Rotschild A., Cooper P. A., Boucher B. J., Tyson J.
Extract | Full Text  
N Engl J Med 1999; 341:1697-1698, Nov 25, 1999. Correspondence

This article has been cited by other articles:

• Laughon, M., O'Shea, M. T., Allred, E. N., Bose, C., Kuban, K., Van Marter, L. J., Ehrenkranz, R. A., Leviton, A., for the ELGAN Study Investigators, (2009). Chronic Lung Disease and Developmental Delay at 2 Years of Age in Children Born Before 28 Weeks' Gestation. Pediatrics 124: 637-648 [Abstract] [Full Text]  
• Bhandari, A., Bhandari, V. (2009). Pitfalls, Problems, and Progress in Bronchopulmonary Dysplasia. Pediatrics 123: 1562-1573 [Abstract] [Full Text]  
• Hind, M, Gilthorpe, A, Stinchcombe, S, Maden, M (2009). Retinoid induction of alveolar regeneration: from mice to man?. Thorax 64: 451-457 [Abstract] [Full Text]  
• Laughon, M., Bose, C., Moya, F., Aschner, J., Donn, S. M., Morabito, C., Cummings, J. J., Segal, R., Guardia, C., Liu, G., for the Surfaxin Study Group, (2009). A Pilot Randomized, Controlled Trial of Later Treatment With a Peptide-Containing, Synthetic Surfactant for the Prevention of Bronchopulmonary Dysplasia. Pediatrics 123: 89-96 [Abstract] [Full Text]  
• Truog, W. E. (2009). 21st-Century Use for Surfactant?. Pediatrics 123: 173-174 [Full Text]  
• Eichenwald, E. C., Stark, A. R. (2008). Management and Outcomes of Very Low Birth Weight. NEJM 358: 1700-1711 [Full Text]  
• Ross, A. C., Li, N.-q. (2007). Retinol Combined with Retinoic Acid Increases Retinol Uptake and Esterification in the Lungs of Young Adult Rats when Delivered by the Intramuscular as well as Oral Routes. J. Nutr. 137: 2371-2376 [Abstract] [Full Text]  
• Ross, A. C., Li, N.-q. (2007). Lung Retinyl Ester Is Low in Young Adult Rats Fed a Vitamin A Deficient Diet after Weaning, despite Neonatal Vitamin A Supplementation and Maintenance of Normal Plasma Retinol. J. Nutr. 137: 2213-2218 [Abstract] [Full Text]  
• Trindade, C. E. P. (2007). International Perspectives: Microelements and Vitamins in the Nutrition of Very Low-birthweight Preterm Infants: A Brazilian Perspective. NeoReviews 8: e3-e13 [Full Text]  
• Shinwell, E S, Lerner-Geva, L, Lusky, A, Reichman, B, in collaboration with the Israel Neonatal Network, (2007). Less postnatal steroids, more bronchopulmonary dysplasia: a population-based study in very low birthweight infants. Arch. Dis. Child. Fetal Neonatal Ed. 92: F30-F33 [Abstract] [Full Text]  
• Ross, A. C., Li, N.-q., Wu, L. (2006). The Components of VARA, a Nutrient-Metabolite Combination of Vitamin A and Retinoic Acid, Act Efficiently Together and Separately to Increase Retinyl Esters in the Lungs of Neonatal Rats. J. Nutr. 136: 2803-2807 [Abstract] [Full Text]  
• Payne, N. R., LaCorte, M., Sun, S., Karna, P., Lewis-Hunstiger, M., Goldsmith, J. P., on behalf of the Breathsavers Group, (2006). Evaluation and Development of Potentially Better Practices to Reduce Bronchopulmonary Dysplasia in Very Low Birth Weight Infants. Pediatrics 118: S65-S72 [Abstract] [Full Text]  
• Ross, A. C., Ambalavanan, N., Zolfaghari, R., Li, N.-q. (2006). Vitamin A combined with retinoic acid increases retinol uptake and lung retinyl ester formation in a synergistic manner in neonatal rats. J. Lipid Res. 47: 1844-1851 [Abstract] [Full Text]  
• Couroucli, X. I., Liang, Y. W., Jiang, W., Barrios, R., Moorthy, B. (2006). Attenuation of Oxygen-Induced Abnormal Lung Maturation in Rats by Retinoic Acid: Possible Role of Cytochrome P4501A Enzymes. J. Pharmacol. Exp. Ther. 317: 946-954 [Abstract] [Full Text]  
• Cho, S. J., George, C. L. S., Snyder, J. M., Acarregui, M. J. (2005). Retinoic Acid and Erythropoietin Maintain Alveolar Development in Mice Treated with an Angiogenesis Inhibitor. Am. J. Respir. Cell Mol. Bio. 33: 622-628 [Abstract] [Full Text]  
• Ehrenkranz, R. A., Walsh, M. C., Vohr, B. R., Jobe, A. H., Wright, L. L., Fanaroff, A. A., Wrage, L. A., Poole, K., for the National Institutes of Child Health and Hu, (2005). Validation of the National Institutes of Health Consensus Definition of Bronchopulmonary Dysplasia. Pediatrics 116: 1353-1360 [Abstract] [Full Text]  
• Truog, W. E. (2005). Chronic Lung Disease and Randomized Interventional Trials: Status in 2005. NeoReviews 6: e278-e288 [Full Text]  
• Christou, H., Brodsky, D. (2005). Lung Injury and Bronchopulmonary Dysplasia in Newborn Infants. J Intensive Care Med 20: 76-87 [Abstract]  
• Mactier, H, Weaver, L T (2005). Vitamin A and preterm infants: what we know, what we don't know, and what we need to know. Arch. Dis. Child. Fetal Neonatal Ed. 90: F103-F108 [Abstract] [Full Text]  
• Ambalavanan, N., Tyson, J. E., Kennedy, K. A., Hansen, N. I., Vohr, B. R., Wright, L. L., Carlo, W. A., and National Institute of Child Health and Human D, (2005). Vitamin A Supplementation for Extremely Low Birth Weight Infants: Outcome at 18 to 22 Months. Pediatrics 115: e249-e254 [Abstract] [Full Text]  
• Spears, K., Cheney, C., Zerzan, J. (2004). Low plasma retinol concentrations increase the risk of developing bronchopulmonary dysplasia and long-term respiratory disability in very-low-birth-weight infants. Am. J. Clin. Nutr. 80: 1589-1594 [Abstract] [Full Text]  
• Watterberg, K. L., Gerdes, J. S., Cole, C. H., Aucott, S. W., Thilo, E. H., Mammel, M. C., Couser, R. J., Garland, J. S., Rozycki, H. J., Leach, C. L., Backstrom, C., Shaffer, M. L. (2004). Prophylaxis of Early Adrenal Insufficiency to Prevent Bronchopulmonary Dysplasia: A Multicenter Trial. Pediatrics 114: 1649-1657 [Abstract] [Full Text]  
• Walsh, M. C., Yao, Q., Gettner, P., Hale, E., Collins, M., Hensman, A., Everette, R., Peters, N., Miller, N., Muran, G., Auten, K., Newman, N., Rowan, G., Grisby, C., Arnell, K., Miller, L., Ball, B., McDavid, G., for the National Institute of Child Health and Hum, (2004). Impact of a Physiologic Definition on Bronchopulmonary Dysplasia Rates. Pediatrics 114: 1305-1311 [Abstract] [Full Text]  
• Mamo, L. B., Suliman, H. B., Giles, B.-L., Auten, R. L., Piantadosi, C. A., Nozik-Grayck, E. (2004). Discordant Extracellular Superoxide Dismutase Expression and Activity in Neonatal Hyperoxic Lung. Am. J. Respir. Crit. Care Med. 170: 313-318 [Abstract] [Full Text]  
• (2003). Statement on the Care of the Child with Chronic Lung Disease of Infancy and Childhood. Am. J. Respir. Crit. Care Med. 168: 356-396 [Full Text]  
• Sharek, P. J., Baker, R., Litman, F., Kaempf, J., Burch, K., Schwarz, E., Sun, S., Payne, N. R. (2003). Evaluation and Development of Potentially Better Practices to Prevent Chronic Lung Disease and Reduce Lung Injury in Neonates. Pediatrics 111: e426-431 [Abstract] [Full Text]  
• Kaempf, J. W., Campbell, B., Sklar, R. S., Arduza, C., Gallegos, R., Zabari, M., Brown, A., McDonald, J. V. (2003). Implementing Potentially Better Practices to Improve Neonatal Outcomes After Reducing Postnatal Dexamethasone Use in Infants Born Between 501 and 1250 Grams. Pediatrics 111: e534-541 [Abstract] [Full Text]  
• Ahmed, M. N., Suliman, H. B., Folz, R. J., Nozik-Grayck, E., Golson, M. L., Mason, S. N., Auten, R. L. (2003). Extracellular Superoxide Dismutase Protects Lung Development in Hyperoxia-exposed Newborn Mice. Am. J. Respir. Crit. Care Med. 167: 400-405 [Abstract] [Full Text]  
• Veness-Meehan, K. A., Pierce, R. A., Moats-Staats, B. M., Stiles, A. D. (2002). Retinoic acid attenuates O2-induced inhibition of lung septation. Am. J. Physiol. Lung Cell. Mol. Physiol. 283: L971-L980 [Abstract] [Full Text]  
• Castro-Alcaraz, S., Greenberg, E. M., Bateman, D. A., Regan, J. A. (2002). Patterns of Colonization With Ureaplasma urealyticum During Neonatal Intensive Care Unit Hospitalizations of Very Low Birth Weight Infants and the Development of Chronic Lung Disease. Pediatrics 110: e45-45 [Abstract] [Full Text]  
• Wright, L. L. (2001). The Role of Follow-up in Randomized Controlled Trials. NeoReviews 2: e257-266 [Full Text]  
• Devaux, Y., Seguin, C., Grosjean, S., de Talance, N., Schwartz, M., Burlet, A., Zannad, F., Meistelman, C., Mertes, P.-M., Ungureanu-Longrois, D. (2001). Retinoic Acid and Lipopolysaccharide Act Synergistically to Increase Prostanoid Concentrations in Rats In Vivo. J. Nutr. 131: 2628-2635 [Abstract] [Full Text]  
• Avent, M., Coile, D., Mathai, L. (2001). Neonatal Chronic Lung Disease. Journal of Pharmacy Practice 14: 181-206 [Abstract]  
• JOBE, A. H., BANCALARI, E. (2001). Bronchopulmonary Dysplasia. Am. J. Respir. Crit. Care Med. 163: 1723-1729 [Full Text]  
• Atkinson, S. A. (2001). Special Nutritional Needs of Infants for Prevention of and Recovery from Bronchopulmonary Dysplasia. J. Nutr. 131: 942S-946 [Abstract] [Full Text]  
• Wardle, S P, Hughes, A, Chen, S, Shaw, N J (2001). Randomised controlled trial of oral vitamin A supplementation in preterm infants to prevent chronic lung disease. Arch. Dis. Child. Fetal Neonatal Ed. 84: 9F-13 [Abstract] [Full Text]  
• Devaux, Y., Grosjean, S., Seguin, C., David, C., Dousset, B., Zannad, F., Meistelman, C., De Talance, N., Mertes, P.-M., Ungureanu-Longrois, D. (2000). Retinoic acid and host-pathogen interactions: effects on inducible nitric oxide synthase in vivo. Am. J. Physiol. Endocrinol. Metab. 279: E1045-E1053 [Abstract] [Full Text]  
• Shenai, J. P., Mellen, B. G., Chytil, F. (2000). Vitamin A Status and Postnatal Dexamethasone Treatment in Bronchopulmonary Dysplasia. Pediatrics 106: 547-553 [Abstract] [Full Text]  
• Van Marter, L. J., Allred, E. N., Pagano, M., Sanocka, U., Parad, R., Moore, M., Susser, M., Paneth, N., Leviton, A., the Neonatology Committee, , for the Developmental Epidemiology Network, (2000). Do Clinical Markers of Barotrauma and Oxygen Toxicity Explain Interhospital Variation in Rates of Chronic Lung Disease?. Pediatrics 105: 1194-1201 [Abstract] [Full Text]  
• Belloni, P. N., Garvin, L., Mao, C.-P., Bailey-Healy, I., Leaffer, D. (2000). Effects of All-Trans-Retinoic Acid in Promoting Alveolar Repair. Chest 117 : 235S-241S [Full Text]  
• Shenai, J. P. (1999). Vitamin A Supplementation in Very Low Birth Weight Neonates: Rationale and Evidence. Pediatrics 104: 1369-1374 [Full Text]  
• Bental, Y. A., Rotschild, A., Cooper, P. A., Boucher, B. J., Tyson, J. (1999). Vitamin A Supplementation for Extremely-Low-Birth-Weight Infants. NEJM 341: 1697-1698 [Full Text]